D
Sell
8/1/2023Downgrade
Biohaven Ltd. (BHVN) was downgraded to D- from D on 8/1/2023 due to a decline in the efficiency index, valuation index and volatility index. Net income declined 28.16% from -$70.49M to -$90.35M, and total capital declined 17.06% from $502.02M to $416.37M.
D
Sell
5/19/2023Upgraded
Biohaven Ltd. (BHVN) was upgraded to D from D- on 5/19/2023 due to a noticeable increase in the growth index and efficiency index. Earnings per share increased from -$3.3152 to -$1.0335, net income increased 64.95% from -$201.11M to -$70.49M, and EBIT increased 58% from -$185.21M to -$77.78M.
D
Sell
5/18/2023Downgrade
Biohaven Ltd. (BHVN) was downgraded to D- from D on 5/18/2023 due to a noticeable decline in the volatility index, growth index and efficiency index. Net income declined 192.08% from -$68.85M to -$201.11M, EBIT declined 173.83% from -$67.64M to -$185.21M, and earnings per share declined from -$1.749 to -$3.3152.
D
Sell
12/16/2022None
Biohaven Ltd. (BHVN) was downgraded to D from U on 12/16/2022.
